We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA's Initiative on Early Drug Trials Gets Mixed Reviews
FDA's Initiative on Early Drug Trials Gets Mixed Reviews
January 20, 2006
The FDA’s latest bid to accelerate new drug approvals, while praised by the pharmaceutical industry, is facing a backlash from some lawmakers and advocacy groups who point to the proposal as evidence the agency is too close to industry and does not place enough emphasis on public safety.